Alzheon Reports Biomarker Findings Supporting Potential Disease-Modifying Effects of Valiltramiprosate in Early Alzheimer’s Disease Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing investigational therapies and diagnostic assays for Alzheimer’s disease (AD) and other neurodegenerative disorders, has announced the peer-reviewed…
Agilent Launches S540MD Slide Scanner in the U.S. Following FDA Clearance Agilent Technologies Inc. has announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner designed to support high-throughput digital pathology workflows.…
eGenesis Reports Sustained Kidney Function and Successful Human Transplantation Following Genetically Engineered Pig Kidney Transplants eGenesis, a biotechnology company focused on developing genetically engineered organs designed for transplantation into humans, has announced encouraging clinical updates from its ongoing Expanded Access…
SinglePass Biopsy Closure Device Demonstrates 100% Technical Success and No Clinically Significant Bleeding in Multicenter Study SinglePass, Inc., developer of the SinglePass biopsy closure device, has announced the publication of new multicenter clinical data evaluating the safety and effectiveness of…
Lōkahi Therapeutics Expands ai² Futures Lab Through New Partnership With San Diego State University Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), has announced a new collaboration with San Diego State University’s (SDSU) Fowler College of Business, expanding the…
Thermo Fisher Scientific Launches Multiskan Ease Absorbance Microplate Reader for Routine Laboratory Applications Thermo Fisher Scientific has announced the launch of the Thermo Scientific™ Multiskan™ Ease Absorbance Microplate Reader, a new single-mode absorbance microplate reader designed to support a broad…
Rapalogix Health Expands Research Capabilities with New Laboratory at Princeton Innovation Center BioLabs Rapalogix Health, a biotechnology company focused on developing longevity-based approaches to skin health, has announced the establishment of dedicated laboratory space at Princeton Innovation Center BioLabs in…
Scholar Rock Advances Apitegromab Development for FSHD with FDA Fast Track and Orphan Drug Designations Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company focused on developing therapies for rare, severe, and debilitating neuromuscular diseases, has announced important regulatory and clinical…
QPS Strengthens Elemental Bioanalysis Capabilities with Acquisition of Two NexION 2200 ICP-MS Systems QPS Holdings, LLC (QPS), a global contract research organization supporting pharmaceutical and drug development programs, has announced a major investment in its elemental bioanalysis infrastructure with the…
Perfuze Reports Strong Final MARRS Pivotal Study Results Supporting Millipede88 Aspiration System in Acute Ischemic Stroke Perfuze, a medical device company focused on advancing stroke intervention through next-generation catheter technology, has announced the publication of final results from its MARRS…
TRex Bio Reports Positive Phase 1a Results for TRB-061, Supporting Treg Activation in Atopic Dermatitis TRex Bio, Inc. (TRexBio), a clinical-stage biotechnology company focused on tissue regulatory T-cell (Treg) biology and the discovery and development of immunoregulatory medicines, has announced…
McKesson to Acquire Precision Medicine Group for Approximately $2.25 Billion to Expand Oncology and Biopharma Services McKesson Corporation (NYSE: MCK) has announced a definitive agreement to acquire Precision Medicine Group, LLC, a global provider of clinical research and biopharmaceutical commercialization…